178 related articles for article (PubMed ID: 16447132)
21. Manufacturing issues related to combining different antigens: an industry perspective.
Van Hoof J
Clin Infect Dis; 2001 Dec; 33 Suppl 4():S346-50. PubMed ID: 11709771
[TBL] [Abstract][Full Text] [Related]
22. Vaccine supply: a cross-national perspective.
Danzon PM; Pereira NS; Tejwani SS
Health Aff (Millwood); 2005; 24(3):706-17. PubMed ID: 15886165
[TBL] [Abstract][Full Text] [Related]
23. The U.S. vaccine supply.
Schwartz HK
N Engl J Med; 2005 Mar; 352(10):1046-7; author reply 1046-7. PubMed ID: 15762001
[No Abstract] [Full Text] [Related]
24. Keys to strengthening the supply of routinely recommended vaccines: view from industry.
Pisano W
Clin Infect Dis; 2006 Mar; 42 Suppl 3():S111-7. PubMed ID: 16447131
[TBL] [Abstract][Full Text] [Related]
25. Vaccine shortages: why they occur and what needs to be done to strengthen vaccine supply.
Klein JO; Myers MG
Pediatrics; 2006 Jun; 117(6):2269-75. PubMed ID: 16740872
[No Abstract] [Full Text] [Related]
26. Update on vaccine liability in the United States: presentation at the National Vaccine Program Office Workshop on strengthening the supply of routinely recommended vaccines in the United States, 12 February 2002.
Evans G
Clin Infect Dis; 2006 Mar; 42 Suppl 3():S130-7. PubMed ID: 16447135
[TBL] [Abstract][Full Text] [Related]
27. Why sole-supplier vaccine markets may be here to stay.
Danzon P; Pereira NS
Health Aff (Millwood); 2005; 24(3):694-6. PubMed ID: 15886161
[TBL] [Abstract][Full Text] [Related]
28. Manufacturing issues with combining different antigens: a regulatory perspective.
Falk LA; Arciniega J; McVittie L
Clin Infect Dis; 2001 Dec; 33 Suppl 4():S351-5. PubMed ID: 11709772
[TBL] [Abstract][Full Text] [Related]
29. No Shot: US Vaccine Prices And Shortages.
Ridley DB; Bei X; Liebman EB
Health Aff (Millwood); 2016 Feb; 35(2):235-41. PubMed ID: 26858375
[TBL] [Abstract][Full Text] [Related]
30. Governments unite to fund vaccine for poor countries.
Cole A
BMJ; 2007 Feb; 334(7589):335. PubMed ID: 17303862
[No Abstract] [Full Text] [Related]
31. Potency assays for therapeutic live whole cell cancer vaccines.
Petricciani J; Egan W; Vicari G; Furesz J; Schild G
Biologicals; 2007 Apr; 35(2):107-13. PubMed ID: 16882459
[TBL] [Abstract][Full Text] [Related]
32. Tailoring the strategies to specific shortages: pneumococcal conjugate vaccine.
Peter G
Clin Infect Dis; 2006 Mar; 42 Suppl 3():S138-40. PubMed ID: 16447136
[TBL] [Abstract][Full Text] [Related]
33. The pediatric vaccine stockpiling problem.
Truong VA
Vaccine; 2012 Sep; 30(43):6175-9. PubMed ID: 22874852
[TBL] [Abstract][Full Text] [Related]
34. Government intervention and innovation in industry: a policy framework.
Abernathy WJ; Chakravarthy BS
Sloan Manage Rev; 1979; ():3-18. PubMed ID: 10248178
[TBL] [Abstract][Full Text] [Related]
35. Indian-born weapons for infectious diseases.
Padmanaban G
Nat Med; 2003 Jul; 9(7):813. PubMed ID: 12835687
[No Abstract] [Full Text] [Related]
36. Response to "Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences".
Proano RA; Jacobson SH; Jokela JA
Vaccine; 2011 Jan; 29(4):615; author reply 616. PubMed ID: 21094271
[No Abstract] [Full Text] [Related]
37. Improving the reliability of the U.S. vaccine supply: an evaluation of alternatives.
Mowery DC; Mitchell V
J Health Polit Policy Law; 1995; 20(4):973-1000. PubMed ID: 8770760
[TBL] [Abstract][Full Text] [Related]
38. Variation in provider vaccine purchase prices and payer reimbursement.
Freed GL; Cowan AE; Gregory S; Clark SJ
Pediatrics; 2008 Dec; 122(6):1325-31. PubMed ID: 19047253
[TBL] [Abstract][Full Text] [Related]
39. Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution.
Rey-Jurado E; Tapia F; Muñoz-Durango N; Lay MK; Carreño LJ; Riedel CA; Bueno SM; Genzel Y; Kalergis AM
Front Immunol; 2018; 9():26. PubMed ID: 29403503
[TBL] [Abstract][Full Text] [Related]
40. Economic and practical challenges to the formulation of vaccines against endemic infectious diseases such as malaria.
Plebanski M; Lopez E; Proudfoot O; Cooke BM; Itzstein Mv; Coppel RL
Methods; 2006 Sep; 40(1):77-85. PubMed ID: 16997716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
